{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:02:46Z","timestamp":1762671766949},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,19]],"date-time":"2009-12-19T00:00:00Z","timestamp":1261180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00774-009-0142-y","type":"journal-article","created":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T12:17:31Z","timestamp":1261138651000},"page":"384-394","source":"Crossref","is-referenced-by-count":17,"title":["Effects of the bisphosphonate risedronate on osteopenia in OASIS-deficient mice"],"prefix":"10.1007","volume":"28","author":[{"given":"Hiroshi","family":"Sekiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichiro","family":"Hino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tsumagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiko","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,19]]},"reference":[{"key":"142_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/355033a0","volume":"355","author":"MJ Gething","year":"1992","unstructured":"Gething MJ, Sambrook J (1992) Protein folding in the cell. Nature 355:33\u201345","journal-title":"Nature"},{"key":"142_CR2","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1126\/science.286.5446.1882","volume":"286","author":"L Ellgaard","year":"1999","unstructured":"Ellgaard L, Molinari M, Helenius A (1999) Setting the standards: quality control in the secretory pathway. Science 286:1882\u20131888","journal-title":"Science"},{"key":"142_CR3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0092-8674(00)80855-7","volume":"101","author":"K Mori","year":"2000","unstructured":"Mori K (2000) Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101:451\u2013454","journal-title":"Cell"},{"key":"142_CR4","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1172\/JCI0216784","volume":"110","author":"D Ron","year":"2002","unstructured":"Ron D (2002) Translational control in the endoplasmic reticulum stress response. J Clin Invest 110:1383\u20131388","journal-title":"J Clin Invest"},{"key":"142_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mrfmmm.2004.06.056","volume":"569","author":"M Schr\u00f6der","year":"2005","unstructured":"Schr\u00f6der M, Kaufman RJ (2005) ER stress and the unfolded protein response. Mutat Res 569:29\u201363","journal-title":"Mutat Res"},{"key":"142_CR6","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1097-2765(01)00264-7","volume":"7","author":"HP Harding","year":"2001","unstructured":"Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H, Sabatini DD, Ron D (2001) Diabetes mellitus and exocrine pancreatic dysfunction in perk\u2212\/\u2212 mice reveals a role for translational control in secretory cell survival. Mol Cell 7:1153\u20131163","journal-title":"Mol Cell"},{"key":"142_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.cdd.4401778","volume":"13","author":"D Lindholm","year":"2006","unstructured":"Lindholm D, Wootz H, Korhonen L (2006) ER stress and neurodegenerative diseases. Cell Death Differ 13:385\u2013392","journal-title":"Cell Death Differ"},{"key":"142_CR8","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1371\/journal.pgen.0040007","volume":"4","author":"TS Lisse","year":"2008","unstructured":"Lisse TS, Thiele F, Fuchs H, Hans W, Przemeck GK, Abe K, Rathkolb B, Quintanilla-Martinez L, Hoelzlwimmer G, Helfrich M, Wolf E, Ralston SH, Hrab\u00e9 de Angelis M (2008) ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta. PLoS Genet 4:e7","journal-title":"PLoS Genet"},{"key":"142_CR9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molmed.2004.12.004","volume":"11","author":"TJ Martin","year":"2005","unstructured":"Martin TJ, Sims NA (2005) Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11:76\u201381","journal-title":"Trends Mol Med"},{"key":"142_CR10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.abb.2008.03.027","volume":"473","author":"K Matsuo","year":"2008","unstructured":"Matsuo K, Irie N (2008) Osteoclast-osteoblast communication. Arch Biochem Biophys 473:201\u2013209","journal-title":"Arch Biochem Biophys"},{"key":"142_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1534-5807(02)00157-0","volume":"2","author":"G Karsenty","year":"2002","unstructured":"Karsenty G, Wagner EF (2002) Reaching a genetic and molecular understanding of skeletal development. Dev Cell 2:389\u2013406","journal-title":"Dev Cell"},{"key":"142_CR12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/dvdy.20603","volume":"235","author":"TA Franz-Odendaal","year":"2006","unstructured":"Franz-Odendaal TA, Hall BK, Witten PE (2006) Buried alive: how osteoblasts become osteocytes. Dev Dyn 235:176\u2013190","journal-title":"Dev Dyn"},{"key":"142_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00198-005-2035-9","volume":"17","author":"S Viguet-Carrin","year":"2006","unstructured":"Viguet-Carrin S, Garnero P, Delmas PD (2006) The role of collagen in bone strength. Osteoporos Int 17:319\u2013336","journal-title":"Osteoporos Int"},{"key":"142_CR14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/nar\/25.1.181","volume":"25","author":"R Dalgleish","year":"1997","unstructured":"Dalgleish R (1997) The human type I collagen mutation database. Nucleic Acids Res 25:181\u2013187","journal-title":"Nucleic Acids Res"},{"key":"142_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","volume":"28","author":"JC Marini","year":"2007","unstructured":"Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD et al (2007) Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 28:209\u2013221","journal-title":"Hum Mutat"},{"key":"142_CR16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2006.08.039","volume":"127","author":"R Morello","year":"2006","unstructured":"Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L et al (2006) CRTAP is required for prolyl 3-hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 127:291\u2013304","journal-title":"Cell"},{"key":"142_CR17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1968","volume":"39","author":"WA Cabral","year":"2007","unstructured":"Cabral WA, Chang W, Barnes AM, Weis M, Scott MA, Leikin S, Makareeva E, Kuznetsova NV, Rosenbaum KN, Tifft CJ, Bulas DI, Kozma C, Smith PA, Eyre DR, Marini JC (2007) Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal\/severe osteogenesis imperfecta. Nat Genet 39:359\u2013365","journal-title":"Nat Genet"},{"key":"142_CR18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0169-328X(99)00102-3","volume":"69","author":"Y Honma","year":"1999","unstructured":"Honma Y, Kanazawa K, Mori T, Tanno Y, Tojo M, Kiyosawa H, Takeda J, Nikaido T, Tsukamoto T, Yokoya S, Wanaka A (1999) Identification of a novel gene, OASIS, which encodes for a putative CREB\/ATF family transcription factor in the long-term cultured astrocytes and gliotic tissue. Brain Res Mol Brain Res 69:93\u2013103","journal-title":"Brain Res Mol Brain Res"},{"key":"142_CR19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ncb1213","volume":"7","author":"S Kondo","year":"2005","unstructured":"Kondo S, Murakami T, Tatsumi K, Ogata M, Kanemoto S, Otori K, Iseki K, Wanaka A, Imaizumi K (2005) OASIS, a CREB\/ATF-family member, modulates UPR signalling in astrocytes. Nat Cell Biol 7:186\u2013194","journal-title":"Nat Cell Biol"},{"key":"142_CR20","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1471-4159.2005.03596.x","volume":"96","author":"T Murakami","year":"2006","unstructured":"Murakami T, Kondo S, Ogata M, Kanemoto S, Saito A, Wanaka A, Imaizumi K (2006) Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stress. J Neurochem 96:1090\u20131100","journal-title":"J Neurochem"},{"key":"142_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s004180100279","volume":"116","author":"T Nikaido","year":"2001","unstructured":"Nikaido T, Yokoya S, Mori T, Hagino S, Iseki K, Zhang Y, Takeuchi M, Takaki H, Kikuchi S, Wanaka A (2001) Expression of the novel transcription factor OASIS, which belongs to the CREB\/ATF family, in mouse embryo with special reference to bone development. Histochem Cell Biol 116:141\u2013148","journal-title":"Histochem Cell Biol"},{"key":"142_CR22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/ncb1963","volume":"11","author":"T Murakami","year":"2009","unstructured":"Murakami T, Saito A, Hino SI, Kondo S, Kanemoto S et al (2009) Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation. Nat Cell Biol 11:1205\u20131211","journal-title":"Nat Cell Biol"},{"key":"142_CR23","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ncb1962","volume":"11","author":"A Saito","year":"2009","unstructured":"Saito A, Hino S, Murakami T, Kanemoto S, Kondo S, Saitoh M, Nishimura R, Yoneda T, Furuichi T, Ikegawa S, Ikawa M, Okabe M, Imaizumi K (2009) Regulation of endoplasmic reticulum stress response by a BBF2H7-mediated Sec23a pathway is essential for chondrogenesis. Nat Cell Biol 11:1197\u20131204","journal-title":"Nat Cell Biol"},{"key":"142_CR24","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1073\/pnas.79.12.3838","volume":"79","author":"GS Barsh","year":"1982","unstructured":"Barsh GS, David KE, Byers PH (1982) Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen. Proc Natl Acad Sci USA 79:3838\u20133842","journal-title":"Proc Natl Acad Sci USA"},{"key":"142_CR25","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1073\/pnas.87.18.7145","volume":"87","author":"J Bonadio","year":"1990","unstructured":"Bonadio J, Saunders TL, Tsai E, Goldstein SA, Morris-Wiman J, Brinkley L, Dolan DF, Altschuler RA, Hawkins JE Jr, Bateman JF, Mascara T, Jaenisch R (1990) Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. Proc Natl Acad Sci USA 87:7145\u20137149","journal-title":"Proc Natl Acad Sci USA"},{"key":"142_CR26","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1073\/pnas.90.5.1701","volume":"90","author":"SD Chipman","year":"1993","unstructured":"Chipman SD, Sweet HO, McBride DJ Jr, Davisson MT, Marks SC Jr, Shuldiner AR, Wenstrup RJ, Rowe DW, Shapiro JR (1993) Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA 90:1701\u20131705","journal-title":"Proc Natl Acad Sci USA"},{"key":"142_CR27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00774-007-0750-3","volume":"25","author":"AS Kamoun-Goldrat","year":"2007","unstructured":"Kamoun-Goldrat AS, Le Merrer MF (2007) Animal models of osteogenesis imperfecta and related syndromes. J Bone Miner Metab 25:211\u2013218","journal-title":"J Bone Miner Metab"},{"key":"142_CR28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/ncpendmet0121","volume":"2","author":"RD Chapurlat","year":"2006","unstructured":"Chapurlat RD, Delmas PD (2006) Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nat Clin Pract Endocrinol Metab 2:211\u2013219","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"142_CR29","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI118722","volume":"97","author":"GA Rodan","year":"1996","unstructured":"Rodan GA, Fleisch HA (1996) Bisphosphonates: mechanisms of action. J Clin Invest 97:2692\u20132696","journal-title":"J Clin Invest"},{"key":"142_CR30","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","volume":"339","author":"FH Glorieux","year":"1998","unstructured":"Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R (1998) Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med 339:947\u2013952","journal-title":"N Engl J Med"},{"key":"142_CR31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/adc.86.5.356","volume":"86","author":"E Astr\u00f6m","year":"2002","unstructured":"Astr\u00f6m E, S\u00f6derh\u00e4ll S (2002) Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 86:356\u2013364","journal-title":"Arch Dis Child"},{"key":"142_CR32","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1210\/en.2003-0717","volume":"144","author":"M Nakamura","year":"2003","unstructured":"Nakamura M, Udagawa N, Matsuura S, Mogi M, Nakamura H, Horiuchi H, Saito N, Hiraoka BY, Kobayashi Y, Takaoka K, Ozawa H, Miyazawa H, Takahashi N (2003) Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. Endocrinology 144:5441\u20135449","journal-title":"Endocrinology"},{"key":"142_CR33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj2530139","volume":"253","author":"C Domenicucci","year":"1988","unstructured":"Domenicucci C, Goldberg HA, Hofmann T, Isenman D, Wasi S, Sodek J (1988) Characterization of porcine osteonectin extracted from foetal calbariae. Biochem J 253:139\u2013151","journal-title":"Biochem J"},{"key":"142_CR34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jcp.21543","volume":"217","author":"J Wei","year":"2008","unstructured":"Wei J, Sheng X, Feng D, McGrath B, Cavener DR (2008) PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation. J Cell Physiol 217:693\u2013707","journal-title":"J Cell Physiol"},{"key":"142_CR35","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478\u20131487","journal-title":"J Bone Miner Res"},{"key":"142_CR36","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1210\/endo.141.12.7921","volume":"141","author":"JE Fisher","year":"2000","unstructured":"Fisher JE, Rodan GA, Reszka AA (2000) In vivo effects of bisphosphonates on the osteoclast mevalonate pathway. Endocrinology 141:4793\u20134796","journal-title":"Endocrinology"},{"key":"142_CR37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s002230010045","volume":"69","author":"NP Camacho","year":"2001","unstructured":"Camacho NP, Raggio CL, Doty SB, Root L, Zraick V, IIg WA, Toledano TR, Boskey AL (2001) A controlled study of the Effects of alendronate in a growing mouse model of osteogenesis imperfecta. Calcif Tissue Int 69:94\u2013101","journal-title":"Calcif Tissue Int"},{"key":"142_CR38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bone.2004.10.006","volume":"36","author":"BM Misof","year":"2005","unstructured":"Misof BM, Roschger P, Baldini T, Raggio CL, Zraick V, Root L, Boskey AL, Klaushofer K, Fratzl P, Camacho NP (2005) Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse. Bone 36:150\u2013158","journal-title":"Bone"},{"key":"142_CR39","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","volume":"104","author":"LI Plotkin","year":"1999","unstructured":"Plotkin LI, Weinstein RS, Parfitt AM, Roberson PK, Manolagas SC, Bellido T (1999) Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest 104:1363\u20131374","journal-title":"J Clin Invest"},{"key":"142_CR40","first-page":"6001","volume":"60","author":"GG Reinholz","year":"2000","unstructured":"Reinholz GG, Getz B, Pederson L, Sanders ES, Subramaniam M, Ingle JN, Spelsberg TC (2000) Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts. Cancer Res 60:6001\u20136007","journal-title":"Cancer Res"},{"key":"142_CR41","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1006\/bbrc.2002.6510","volume":"291","author":"V Viereck","year":"2002","unstructured":"Viereck V, Emons G, Lauck V, Frosch KH, Blaschke S, Gr\u00fcndker C, Hofbauer LC (2002) Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts. Biochem Biophys Res Commun 291:680\u2013686","journal-title":"Biochem Biophys Res Commun"},{"key":"142_CR42","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1172\/JCI0215952","volume":"110","author":"F Rouch","year":"2002","unstructured":"Rouch F, Travers R, Plotkin H, Glorieux FH (2002) The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest 110:1293\u20131299","journal-title":"J Clin Invest"},{"key":"142_CR43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH704>3.0.CO;2-U","volume":"192","author":"P Sarathchandra","year":"2000","unstructured":"Sarathchandra P, Pope FM, Kayser MV, Ali SY (2000) A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype. J Pathol 192:385\u2013395","journal-title":"J Pathol"},{"key":"142_CR44","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.matbio.2007.06.005","volume":"26","author":"A Forlino","year":"2007","unstructured":"Forlino A, Kuznetsova NV, Mrini JC, Leikin S (2007) Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI. Matrix Biol 26:604\u2013614","journal-title":"Matrix Biol"},{"key":"142_CR45","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1359\/jbmr.2001.16.9.1665","volume":"16","author":"JM Alexander","year":"2001","unstructured":"Alexander JM, Bab I, Fish S, M\u00fcller R, Uchiyama T, Gronowicz G, Nahounou M, Zhao Q, White DW, Chorev M, Gazit D, Rosenblatt M (2001) Human parathyroid hormone 1\u201334 reverses bone loss in ovariectomized mice. J Bone Miner Res 16:1665\u20131673","journal-title":"J Bone Miner Res"},{"key":"142_CR46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bone.2003.12.006","volume":"34","author":"PJ Kostenuik","year":"2004","unstructured":"Kostenuik PJ, Bolon B, Morony S, Daris M, Geng Z, Carter C, Sheng J (2004) Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. Bone 34:656\u2013664","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0142-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-009-0142-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0142-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T09:47:40Z","timestamp":1590313660000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-009-0142-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,19]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["142"],"URL":"https:\/\/doi.org\/10.1007\/s00774-009-0142-y","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,19]]}}}